APA (7th ed.) Citation

GD, H., J, D., HX, H., & J, Z. (2023). ALOX5AP suppresses osteosarcoma progression via Wnt/β-catenin/EMT pathway and associates with clinical prognosis and immune infiltration. Journal of orthopaedic surgery and research, 18(1), 446. https://doi.org/10.1186/s13018-023-03919-x

Chicago Style (17th ed.) Citation

GD, Han, Dai J, Hui HX, and Zhu J. "ALOX5AP Suppresses Osteosarcoma Progression via Wnt/β-catenin/EMT Pathway and Associates with Clinical Prognosis and Immune Infiltration." Journal of Orthopaedic Surgery and Research 18, no. 1 (2023): 446. https://doi.org/10.1186/s13018-023-03919-x.

MLA (9th ed.) Citation

GD, Han, et al. "ALOX5AP Suppresses Osteosarcoma Progression via Wnt/β-catenin/EMT Pathway and Associates with Clinical Prognosis and Immune Infiltration." Journal of Orthopaedic Surgery and Research, vol. 18, no. 1, 2023, p. 446, https://doi.org/10.1186/s13018-023-03919-x.